HTG Molecular
In Brief This Week: Personalis, Burning Rock, Thermo Fisher, Caris Life Sciences, More
News items for the week of Jan. 3, 2023.
HTG Molecular Diagnostics to Raise $10M in Public Offering
The firm plans to use the net proceeds from the offering for general corporate purposes including research and development, clinical trials, capital expenditures, and working capital.
HTG Molecular Diagnostics to Implement Reverse Stock Split
Last month, the company reported a 48 percent year-over-year drop in third quarter revenues as it repositions itself as a developer of drug discovery technologies.
Earnings Roundup: HTG Molecular, T2 Biosystems, Co-Diagnostics, Biocept, Oncocyte, OpGen
The genomic and diagnostics firms posted quarterly financial results late this week.
HTG Molecular, OmiCure Partner to Use Transcriptome Panel to Guide Cancer Therapy
Samples from OmiCure will be sent to HTG's laboratory for testing with its transcriptome panel, and the data will be analyzed by OmiCure.